Application of linaclotide in bowel preparation for colonoscopy in patients with constipation: A prospective randomized controlled study

被引:0
|
作者
Xu, Haoxin [1 ]
He, Zhu [2 ]
Liu, Yulin [2 ]
Xu, Hong [2 ]
Liu, Pengfei [3 ]
机构
[1] Second Hosp Longyan, Canc Dept, Longyan, Fujian, Peoples R China
[2] First Hosp Jilin Univ, Dept Gastroenterol, Changchun, Jilin, Peoples R China
[3] Fujian Med Univ, Hosp Longyan 1, Longyan, Fujian, Peoples R China
关键词
bowel preparation; colonoscopy; constipation; linaclotide; GUANYLATE-CYCLASE-C; TECHNICAL PERFORMANCE; CECAL INTUBATION; INSERTION TIME; QUALITY; IMPACT; PREDICTORS; SOCIETY;
D O I
10.1111/jgh.16734
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aim Colonoscopy plays a crucial role in the early diagnosis and treatment of colorectal cancer. Adequate bowel preparation is essential for clear visualization of the colonic mucosa and lesion detection. However, inadequate bowel preparation is common in patients with constipation, and there is no standardized preparation protocol for these patients. This study aimed to explore the effectiveness and tolerability of a pre-colonoscopy combination regimen of linaclotide and polyethylene glycol (PEG). Methods In this prospective, single-center, randomized controlled trial, 322 participants were divided into two groups: a 3-L PEG + 870-mu g linaclotide group (administered as a single dose for 3 days) and a 4-L PEG group. The primary endpoints were the Boston Bowel Preparation Scale (BBPS) score and the rate of adequate and excellent bowel preparation. Secondary endpoints were the rates of detection of colonic adenomas and polyps, cecal intubation rates, colonoscopy time, adverse reactions, patient satisfaction, and physician satisfaction. Results The study included 319 patients. The 3-L PEG + linaclotide group showed significantly higher rates of adequate and excellent bowel preparation than the 4-L PEG group (89.4% vs 73.6% and 37.5% vs 25.3%, respectively; P < 0.05). The mean BBPS score for the right colon in the 3-L PEG + linaclotide group was significantly higher than that in the 4-L PEG group. There were no significant between-group differences regarding the detection rates of colonic polyps and adenomas (44.4% vs 37.7% and 23.1% vs 20.1%, respectively; P > 0.05). There were no significant between-group differences regarding cecal intubation rates, colonoscopy operation, and withdrawal times. However, patient tolerance and sleep quality were better in the 3-L PEG + linaclotide group. Conclusion The combination of 3-L PEG and 870-mu g linaclotide, because of its lower volume of intake, can be considered as an alternative bowel preparation regimen for constipated patients undergoing colonoscopy, especially for the elderly.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] DIGITAL NAVIGATION IMPROVES NO-SHOW RATES AND BOWEL PREPARATION QUALITY FOR PATIENTS UNDERGOING COLONOSCOPY - A RANDOMIZED CONTROLLED STUDY
    Solonowicz, Olga
    Stier, Matthew W.
    Kim, Karen
    Kupfer, Sonia S.
    Sengupta, Neil
    GASTROENTEROLOGY, 2020, 158 (06) : S176 - S176
  • [32] Colonoscopy Without Insufflation: A Prospective Randomized Controlled Study
    Kantsevoy, Sergey
    Bitner, Marianne
    Hockett, Deborah
    Pennington, Deborah
    Chapman, Karen
    Maier, Kathleen
    Vilches, April
    O'Neil, Barbara
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S207 - S208
  • [33] Linaclotide in the treatment of patients with irritable bowel syndrome and constipation - analysis of an opportunity
    Carballo, Fernando
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2013, 105 (06) : 345 - 354
  • [34] A Prospective Study Evaluating the Effect of BMI on Bowel Preparation for Colonoscopy
    Anklesaria, Ava
    Venugopal, Sushma
    Levine, Chaya
    Pagala, Murali
    Agrawal, Manasi
    Li, Jianjun
    Iswara, Kadirawelpillai
    Rahmani, Rabin
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S405 - S405
  • [35] QUALITY OF BOWEL PREPARATION FOR COLONOSCOPY IN HOSPITALIZED PATIENTS: RESULTS OF THE MULTICENTER PROSPECTIVE PISCOPO STUDY
    Rotondano, G.
    Rispo, A.
    Bottiglieri, M. E.
    De Luca, L.
    Lamanda, R.
    Orsini, L.
    Bruzzese, D.
    Galloro, G.
    DIGESTIVE AND LIVER DISEASE, 2015, 47 : E75 - E75
  • [36] PROSPECTIVE RANDOMIZED TRIAL EVALUATING ORAL SIMETHICONE ADDITION TO BOWEL PREPARATION FOR COLONOSCOPY
    Skead, Charlenn
    Bhanot, Shiv
    Towle, Melissa
    Dhalla, Sonny S.
    GASTROINTESTINAL ENDOSCOPY, 2018, 87 (06) : AB523 - AB523
  • [37] A Customized Mobile Application in Colonoscopy Preparation: A Randomized Controlled Trial
    Sharara, Ala I.
    Chalhoub, Jean M.
    Beydoun, Maya
    Shayto, Rani H.
    Chehab, Hamed
    Harb, Ali H.
    Mourad, Fadi H.
    Sarkis, Fayez S.
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2017, 8
  • [38] Linaclotide Improves Abdominal Pain and Bowel Habits in a Phase IIb Study of Patients With Irritable Bowel Syndrome With Constipation
    Johnston, Jeffrey M.
    Kurtz, Caroline B.
    MacDougall, James E.
    Lavins, Bernard J.
    Currie, Mark G.
    Fitch, Donald A.
    O'Dea, Chris
    Baird, Mollie
    Lembo, Anthony J.
    GASTROENTEROLOGY, 2010, 139 (06) : 1877 - U139
  • [39] Effects of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation or Chronic Constipation: A Meta-analysis
    Videlock, Elizabeth J.
    Cheng, Vivian
    Cremonini, Filippo
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2013, 11 (09) : 1084 - U82
  • [40] Determining an Optimal Dose of Linaclotide in Use in Japanese Patients With Irritable Bowel Syndrome With Constipation: A Phase II Randomized, Double-Blind, Placebo-Controlled Study
    Fukudo, Shin
    Nakajima, Atsushi
    Fujiyama, Yoshihide
    Kosako, Masanori
    Nakagawa, Ayako
    Akiho, Hiraku
    Nakashima, Yoshihiro
    Johnston, Jeffrey
    Miwa, Hiroto
    GASTROENTEROLOGY, 2016, 150 (04) : S735 - S735